Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tryptophan 2-monooxygenase is a flavin adenine dinucleotide (FAD)-dependent oxidoreductase enzyme, primarily found in plant-associated bacteria such as *Pseudomonas savastanoi*. It catalyzes the oxidative decarboxylation of L-tryptophan to indole-3-acetamide (IAM), carbon dioxide, and water, using molecular oxygen as a co-substrate. This reaction is the initial step in the synthesis of indole-3-acetic acid (IAA), the main plant growth hormone known as auxin. The enzyme plays a key role in plant-pathogen interactions resulting in gall formation (crown gall disease) and is of significant interest in metabolic engineering for biosynthesis of auxins and related compounds. Structurally, TMO is closely related to the monoamine oxidase family of flavoenzymes and is characterized by conserved residues important for substrate binding and catalysis[1][2][3][4][5][6].
Catalyzes oxidative decarboxylation of L-tryptophan, producing indole-3-acetamide, a precursor in the auxin (IAA) biosynthetic pathway[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tryptophan 2-monooxygenase (TMO).